Robert Kennedy, Jr. actually said...
At very least the label [for mifepristone] should be changed.
Context
Kennedy suggests reviewing mifepristone's labeling due to safety concerns raised by a report.
05/14/2025
Kennedy suggests reviewing mifepristone's labeling due to safety concerns raised by a report.
05/14/2025